Form 4 for PRU Prudential Financial
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-14 · accession 0001127602-23-005584 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-16 | 2023-02-14 | PRU | TANJI KENNETH | EVP, CFO | M - OptEx | $0.00 | +14.6K | 50.0K | +41% | $0 |
| D | 2023-02-16 | 2023-02-14 | PRU | TANJI KENNETH | EVP, CFO | F - Tax | $103.27 | -6,051 | 44.0K | -12% | -$624.9K |
| DM | 2023-02-16 | 2023-02-14 | PRU | TANJI KENNETH | EVP, CFO | A - Grant | $0.00 | +39.2K | 29.4K | New | $0 |
| D | 2023-02-16 | 2023-02-14 | PRU | TANJI KENNETH | EVP, CFO | M - OptEx | $0.00 | -16.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | M | A | 14,614 | $0.00 | 50,026 | D | — | — | (F1) The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. |
| 2 | Common | Common Stock | 2023-02-14 | F | D | 6,051 | $103.27 | 43,975 | D | — | — | (F2) Represents shares withheld for the payment of taxes. |
| 3 | Derivative | 2023 Restricted Stock Units | 2023-02-14 | A | A | 9,805 | $0.00 | 9,805 | D | $0.00 · — to — | 9,805 Common Stock | (F4) The Restricted Stock Units convert to common stock on a 1 to 1 basis. (F5) The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. |
| 4 | Derivative | 2020 Performance Share | 2023-02-14 | M | D | 16,273 | $0.00 | 0 | D | — · — to — | 16,273 Common Stock | (F1) The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. |
| 5 | Derivative | 2023 Performance Shares | 2023-02-14 | A | A | 29,414 | $0.00 | 29,414 | D | $0.00 · — to — | 29,414 Common Stock | (F6) The performance shares convert to common stock on a 1 to 1 basis. (F7) Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. |